Biomarin Pharmaceutical Inc. (BMRN)
NASDAQ · Healthcare
Biomarin Pharmaceutical Inc. Cash on Hand 2008–2025
Biomarin Pharmaceutical Inc. annual cash on hand history from 2009 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- Biomarin Pharmaceutical Inc. cash on hand as of December 31, 2025: 1.31B, a 39.12% increase year-over-year.
- Biomarin Pharmaceutical Inc. cash on hand for 2025 were 1.31B, a 39.12% increase from 2024.
- Biomarin Pharmaceutical Inc. cash on hand for 2024 were 942.8M, a 24.86% increase from 2023.
- Biomarin Pharmaceutical Inc. cash on hand for 2023 were 755.1M, a 4.22% increase from 2022.
- Biomarin Pharmaceutical Inc. cash on hand for 2022 were 724.5M.
Cash on Hand
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Biomarin Pharmaceutical Inc. Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2025 | $1,312 |
| 2024 | $943 |
| 2023 | $755 |
| 2022 | $725 |
| 2021 | $587 |
| 2020 | $649 |
| 2019 | $437 |
| 2018 | $494 |
| 2017 | $598 |
| 2016 | $408 |
| 2015 | $397 |
| 2014 | $875 |
| 2013 | $569 |
| 2012 | $181 |
| 2011 | $46 |
Biomarin Pharmaceutical Inc. Cash on Hand — FAQ
Biomarin Pharmaceutical Inc. (BMRN) cash on hand over the last 18 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BMRN's cash on hand history?
The chart and table above show Biomarin Pharmaceutical Inc.'s cash on hand by year and by quarter, including the growth rate.